FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> Buyout | Sanofi-Aventis | Zentiva | PPF

PPF leaves Zentiva to Sanofi

Tools

PPF Group has bowed out of the competition for the Czech generics maker Zentiva, saying it has "certain doubts about the real value of the company"--and that it doesn't want to end up in a bidding war with Sanofi-Aventis. The news prompted Sanofi to reiterate its 1,050 koruna-per-share offer, which values the company at $2.69 billion.

No word yet from Zentiva management, who quickly rejected PPF's lower offer--950 koruna--and, after some deliberation, came out against Sanofi's, too. As you know, Sanofi already owns 25 percent of Zentiva, while PPF together with an Italian insurer holds 19 percent.

- check out PPF's release
- read the story at MarketWatch

Related Articles:
Zentiva spurns Sanofi's buyout offer
Sanofi launches $1.92B Zentiva offer
Sanofi makes $2 billion generics move
Zentiva board rejects PPF bid
Will Zentiva find itself in bidding war?

More stories about PPF   Buyout   Sanofi-Aventis   Zentiva  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 14 + 27?
To combat spam, please solve the math question above.